• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管内皮生长因子受体Flt-1介导生物学活性。胎盘生长因子在单核细胞活化和趋化作用中的功能作用探讨。

The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.

作者信息

Clauss M, Weich H, Breier G, Knies U, Röckl W, Waltenberger J, Risau W

机构信息

Abteilung für Molekulare Zellbiologie, Max-Planck-Institut für Physiologische und Klinische Forschung, D-61231 Bad Nauheim, Germany.

出版信息

J Biol Chem. 1996 Jul 26;271(30):17629-34. doi: 10.1074/jbc.271.30.17629.

DOI:10.1074/jbc.271.30.17629
PMID:8663424
Abstract

Two distinct receptors for vascular endothelial growth factor (VEGF), the tyrosine kinase receptors Flt-1 and Flk-1/KDR, have been described. In this study we show that monocytes, in contrast to endothelium, express only the VEGF receptor Flt-1, and that this receptor specifically binds also the VEGF homolog placenta growth factor (PlGF). Both VEGF and PlGF stimulate tissue factor production and chemotaxis in monocytes at equivalent doses. In contrast, endothelial cells expressing both the Flt-1 and the Flk-1/KDR receptors produce more tissue factor upon stimulation with VEGF than after stimulation with PlGF. Neutralizing antibodies to the KDR receptor reduce the VEGF-stimulated tissue factor induction in endothelial cells to levels obtained by stimulation with PlGF alone, but do not affect PlGF-induced tissue factor induction in endothelial cells nor the VEGF-dependent tissue factor production in monocytes. These findings strongly suggest Flt-1 as a functional receptor for VEGF and PlGF in monocytes and endothelial cells and identify this receptor as a mediator of monocyte recruitment and procoagulant activity.

摘要

已发现血管内皮生长因子(VEGF)有两种不同的受体,即酪氨酸激酶受体Flt-1和Flk-1/KDR。在本研究中,我们发现,与内皮细胞不同,单核细胞仅表达VEGF受体Flt-1,且该受体也能特异性结合VEGF同源物胎盘生长因子(PlGF)。VEGF和PlGF以等效剂量刺激单核细胞产生组织因子并引起趋化作用。相比之下,同时表达Flt-1和Flk-1/KDR受体的内皮细胞在受到VEGF刺激后比受到PlGF刺激后产生更多的组织因子。抗KDR受体的中和抗体可将VEGF刺激的内皮细胞中组织因子的诱导作用降低至仅用PlGF刺激所达到的水平,但不影响PlGF诱导的内皮细胞中组织因子的诱导作用,也不影响单核细胞中VEGF依赖性组织因子的产生。这些发现有力地表明Flt-1是单核细胞和内皮细胞中VEGF和PlGF的功能性受体,并确定该受体是单核细胞募集和促凝血活性的介质。

相似文献

1
The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.血管内皮生长因子受体Flt-1介导生物学活性。胎盘生长因子在单核细胞活化和趋化作用中的功能作用探讨。
J Biol Chem. 1996 Jul 26;271(30):17629-34. doi: 10.1074/jbc.271.30.17629.
2
Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.胎盘生长因子刺激丝裂原活化蛋白激酶和有丝分裂活性,但不刺激磷脂酶C-γ以及表达Flt 1的内皮细胞的迁移。
Oncogene. 1998 Jan 22;16(3):359-67. doi: 10.1038/sj.onc.1201545.
3
Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.Flt-1而非KDR/Flk-1酪氨酸激酶是胎盘生长因子的受体,胎盘生长因子与血管内皮生长因子相关。
Cell Growth Differ. 1996 Feb;7(2):213-21.
4
Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.促甲状腺激素(TSH)在培养的甲状腺细胞以及用硫脲嘧啶喂养的大鼠甲状腺中上调血管生成因子胎盘生长因子(PlGF)、血管内皮生长因子(VEGF)及其受体(Flt-1、Flk-1/KDR),提示存在一种TSH依赖性旁分泌机制参与甲状腺肿的血管过度增生。
Oncogene. 1997 Nov 27;15(22):2687-98. doi: 10.1038/sj.onc.1201456.
5
Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines.血管内皮生长因子(VEGF)上调及胎盘生长因子(PlGF)下调与人类甲状腺肿瘤及细胞系中的恶性肿瘤相关。
Oncogene. 1995 Oct 19;11(8):1569-79.
6
Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.鉴定血管内皮生长因子与KDR和FLT-1受体结合的决定因素。通过定点诱变产生受体选择性VEGF变体。
J Biol Chem. 1996 Mar 8;271(10):5638-46. doi: 10.1074/jbc.271.10.5638.
7
Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.人类单核细胞对血管内皮生长因子(VEGF)的应答迁移是通过VEGF受体flt-1介导的。
Blood. 1996 Apr 15;87(8):3336-43.
8
Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.利用一种针对血管内皮生长因子(VEGF)激酶受体(fms样酪氨酸激酶受体和含激酶插入结构域的受体)的双功能双抗体完全抑制VEGF活性。
Cancer Res. 2001 Oct 1;61(19):7002-8.
9
Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.胎盘生长因子。在体内外增强血管内皮生长因子的生物活性,与Flt-1具有高亲和力结合,但与Flk-1/KDR无结合。
J Biol Chem. 1994 Oct 14;269(41):25646-54.
10
Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.胎盘生长因子/血管内皮生长因子异二聚体。内皮细胞活性、肿瘤细胞表达以及与Flk-1/KDR的高亲和力结合。
J Biol Chem. 1996 Feb 9;271(6):3154-62. doi: 10.1074/jbc.271.6.3154.

引用本文的文献

1
Preoperative Intravitreal Conbercept Injection Reduced Both Angiogenic and Inflammatory Cytokines in Patients With Proliferative Diabetic Retinopathy.术前玻璃体内注射康柏西普可降低增生型糖尿病视网膜病变患者的血管生成和炎症细胞因子。
J Diabetes Res. 2024 Sep 14;2024:2550367. doi: 10.1155/2024/2550367. eCollection 2024.
2
Targeting NGF but not VEGFR1 or BDNF signaling reduces endometriosis-associated pain in mice.靶向神经生长因子(NGF)而非血管内皮生长因子受体1(VEGFR1)或脑源性神经营养因子(BDNF)信号通路可减轻小鼠子宫内膜异位症相关疼痛。
J Adv Res. 2025 Jul;73:593-605. doi: 10.1016/j.jare.2024.08.017. Epub 2024 Aug 12.
3
FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer.
在癌细胞中激活 FLT1 可促进乳腺癌对 PARP 抑制剂的耐药性。
EMBO Mol Med. 2024 Aug;16(8):1957-1980. doi: 10.1038/s44321-024-00094-2. Epub 2024 Jul 2.
4
Aflibercept Off-Target Effects in Diabetic Macular Edema: An In Silico Modeling Approach.阿柏西普在糖尿病性黄斑水肿中的非靶点作用:一种计算机建模方法。
Int J Mol Sci. 2024 Mar 23;25(7):3621. doi: 10.3390/ijms25073621.
5
Exploring the Impact of Saccharin on Neovascular Age-Related Macular Degeneration: A Comprehensive Study in Patients and Mice.探讨糖精对新生血管性年龄相关性黄斑变性的影响:一项在患者和小鼠中的综合研究。
Invest Ophthalmol Vis Sci. 2024 Apr 1;65(4):5. doi: 10.1167/iovs.65.4.5.
6
Placental and Renal Pathways Underlying Pre-Eclampsia.子痫前期的胎盘和肾脏通路
Int J Mol Sci. 2024 Feb 27;25(5):2741. doi: 10.3390/ijms25052741.
7
The multifaceted role of placental growth factor in the pathogenesis and progression of bronchial asthma and pulmonary fibrosis: Therapeutic implications.胎盘生长因子在支气管哮喘和肺纤维化发病机制及进展中的多方面作用:治疗意义
Genes Dis. 2022 Nov 14;10(4):1537-1551. doi: 10.1016/j.gendis.2022.10.017. eCollection 2023 Jul.
8
Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer.组织因子(凝血因子III):一种有望针对癌症进行靶向及重新靶向的潜在双刃剑分子。
Biomark Res. 2023 Jun 6;11(1):60. doi: 10.1186/s40364-023-00504-6.
9
The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors.肿瘤微环境细胞的代谢谱和细胞内信号通路在实体瘤血管生成中的作用。
Cell Commun Signal. 2022 Nov 23;20(1):186. doi: 10.1186/s12964-022-00951-y.
10
A Review of Intraocular Biomolecules in Retinal Vein Occlusion: Toward Potential Biomarkers for Companion Diagnostics.视网膜静脉阻塞中眼内生物分子的综述:迈向伴随诊断的潜在生物标志物
Front Pharmacol. 2022 Apr 26;13:859951. doi: 10.3389/fphar.2022.859951. eCollection 2022.